Delaware Code § 24-2549A

Dispensing and substitution of biological products [Effective until June 30, 2026]
Open in Lexace · Ask the AI about this section
(a) A pharmacist may substitute for a prescribed biological product only if:
(1) The practitioner has not expressly prohibited substitution in a manner specified in § 2549 of this title;
(2) The product to be substituted has been designated by the Federal Food and Drug Administration as interchangeable with or
therapeutically equivalent to the prescribed product;
(3) The pharmacist informs the patient or the patient's adult representative that an interchangeable biological product has been
dispensed; and
(4) The pharmacist indicates on the prescription and on the prescription label the name of the manufacturer of the interchangeable
biological product substituted unless the practitioner indicates otherwise.
(b) If a biological product is dispensed, the pharmacist or the pharmacist's designee shall, within a reasonable time but not to exceed 10
days following dispensing, communicate to the practitioner the name and manufacturer of the biological product dispensed, by:
(1) Recording such information in an interoperable electronic health records system shared with the prescribing practitioner, to the
extent such a system is in place between a pharmacist and practitioner; or
(2) In the case where electronic health records are not in place between a pharmacist and a practitioner, communicating such
information to the practitioner using any prevailing means available. No communication is required under this subsection where there is
no interchangeable or therapeutically equivalent biological product for the prescribed biological product, or where a refill prescription is
not changed from the biological product originally dispensed.
(c) The pharmacy shall maintain a record of the biological product dispensed as required in § 2532 of this title.
(d) The Board of Pharmacy shall maintain a link on its web site to the current list of all biological products determined by the Federal
Food and Drug Administration to be interchangeable with a specific biological product.
(e) Hospital pharmacies shall be exempt from the requirements of subsection (b) of this section.

‹ Prev All Delaware sections Next ›


Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.